tropomyosin receptor kinase C modulator (Netris pharma)

N/A

Report date: 2025/03/20 09:36:10
NME

Base Information

Drug Nametropomyosin receptor kinase C modulator (Netris pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 3 modulators
TargetsNeurotrophic tyrosine kinase receptor type 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNetris Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNetris Pharma
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A